Founded in 2016, Ambrosia is providing innovation in healthcare. We are currently treating patients in all 50 states.
Our registered, approved clinical trial successfully conducted from 2016 to 2018 found statistically significant improvements in biomarkers related to Alzheimer's disease, cancer, inflammation, and stem cells after a single treatment with young blood (donor age 16 to 25). Patients in the clinical trial reported subjective improvements in athletics, memory, skin quality, sleep, and many other areas.
You must be at least 30 years old to receive this treatment. It is an outpatient procedure. We do not work directly with donors. Our blood is obtained from licensed blood banks within the United States and is matched to your blood type.
Ambrosia was founded by Jesse Karmazin, MD. Dr. Karmazin is a graduate of Princeton University and Stanford University School of Medicine. He has worked in science policy in Washington, DC and for two Harvard hospitals.
The treatments we offer, infusions of blood products, are approved in the United States.
We ship directly to your personal physician anywhere in the United States and provide all of the necessary training to them at the following prices. If you do not have a physician who is able to perform this procedure, please contact us and we will assist you with scheduling an appointment with a physician in the Ambrosia network, for example in San Francisco.
1 liter $5500
2 liters $8000
If you are a physician or blood bank who would like to work with us, or an accredited investor who is interested in investing, please contact us using the contact form below.